![Peter Anastasiou](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter Anastasiou
Chief Operating Officer at
HARMONY BIOSCIENCES HOLDINGS, INC.
Net worth: - $ as of 29/09/2026
Profile
Mr. Peter E.
Anastasiou is a Chief Operating Officer & Senior EVP at Harmony Biosciences Holdings, Inc. He is on the Board of Directors at Pharmaceutical Research & Manufacturers of America.
Mr. Anastasiou was previously employed as a Chief Executive Officer & Director by Capsida Biotherapeutics, Inc., an Executive Vice President-North America by H.
Lundbeck A/S, a Vice President-Marketing by Neuronetics, Inc., a Marketing Director by Bristol Myers Squibb Co., a Principal by Eli Lilly & Co., and a President by Lundbeck Seattle BioPharmaceuticals, Inc. He received his undergraduate degree from Albion College and an MBA from Kelley School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 01/04/2026 | 0 ( -.--% ) | - $ | 29/09/2026 |
Peter Anastasiou active positions
| Companies | Position | Start |
|---|---|---|
| HARMONY BIOSCIENCES HOLDINGS, INC. | Chief Operating Officer | 01/04/2026 |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Director/Board Member | 30/06/2017 |
Former positions of Peter Anastasiou
| Companies | Position | End |
|---|---|---|
Capsida Biotherapeutics, Inc.
 Capsida Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in the development of gene therapies for life threatening genetic disorders | Chief Executive Officer | 30/09/2025 |
| H. LUNDBECK A/S | Corporate Officer/Principal | 30/12/2021 |
| ALDER BIOPHARMACEUTICALS, INC. | President | - |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
| BRISTOL-MYERS SQUIBB COMPANY | Sales & Marketing | - |
Education of Peter Anastasiou
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
68
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
H. Lundbeck A/S
 H. Lundbeck A/S Pharmaceuticals: MajorHealth Technology Engages in the research, development, production and sale of pharmaceuticals for the treatment of brain diseases | Health Technology |
Neuronetics, Inc.
 Neuronetics, Inc. Medical SpecialtiesHealth Technology Develops and commercializes non-invasive therapies for psychiatric and neurological disorders | Health Technology |
Albion College
 Albion College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
Lundbeck Seattle BioPharmaceuticals, Inc.
 Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that specializes in research and develops transformative therapies for brain diseases | Health Technology |
Kelley School of Business
 Kelley School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harmony Biosciences Holdings, Inc.
 Harmony Biosciences Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies for patients living with rare neurological disorders | Health Technology |
Capsida Biotherapeutics, Inc.
Capsida Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in the development of gene therapies for life threatening genetic disorders | Health Technology |
- Stock Market
- Insiders
- Peter Anastasiou
